Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$50.62+2.40 (+4.98%)
Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –
Prestige Consumer Healthcare total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Prestige Consumer Healthcare's total debt was $2.02B at Jun 30, 2026. For fiscal 2026 it was $993.95M, down 12.4% from the year before. Over ten years it grew -4.4% a year on average. The highest annual figure on record is $2.19B in fiscal 2017.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $993.95M | -12.4% |
| FY2024 | Mar 31, 2024 | $1.14B | -15.7% |
| FY2023 | Mar 31, 2023 | $1.35B | -8.9% |
| FY2022 | Mar 31, 2022 | $1.48B | -0.2% |
| FY2021 | Mar 31, 2021 | $1.48B | -14.5% |
| FY2020 | Mar 31, 2020 | $1.73B | -3.8% |
| FY2019 | Mar 31, 2019 | $1.80B | -9.8% |
| FY2018 | Mar 31, 2018 | $1.99B | -9.2% |
| FY2017 | Mar 31, 2017 | $2.19B | +35.0% |
| FY2016 | Mar 31, 2016 | $1.63B | +4.1% |
| FY2015 | Mar 31, 2015 | $1.56B | +67.1% |
| FY2014 | Mar 31, 2014 | $934.41M | -3.8% |
| FY2013 | Mar 31, 2013 | $970.90M | -13.6% |
| FY2012 | Mar 31, 2012 | $1.12B | +130.8% |
| FY2011 | Mar 31, 2011 | $486.95M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $2.02B | +83.4% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $993.95M | -12.4% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $1.00B | -17.4% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $1.06B | -16.9% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $1.10B | -17.3% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $1.14B | -15.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $1.21B | -16.0% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $1.28B | -12.4% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $1.33B | -10.7% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $1.35B | -8.9% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $1.44B | -7.1% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $1.46B | -10.2% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $1.49B | -3.6% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $1.48B | -0.2% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $1.55B | +0.1% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $1.62B | +4.6% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $1.55B | -4.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $1.48B | -14.5% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $1.55B | -9.0% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $1.55B | -11.7% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $1.62B | -8.9% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $1.73B | -3.8% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $1.70B | -7.7% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $1.75B | -7.5% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $1.78B | -10.8% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $1.80B | -9.8% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $1.84B | -10.3% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $1.90B | -9.4% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $1.99B | -7.1% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $1.99B | -9.2% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $2.05B | +45.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $2.09B | +41.4% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $2.15B | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $2.19B | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $1.42B | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $1.48B | – |
See a number that looks wrong?